Exchange: NYSE·Updated 05:20 PM EDT
INSP logo

INSPInspire Medical Systems Inc

$46.95
$1.49
(3.28%)
Today
Closed $46.95
$0.70
(1.49%)
After Hours
EarningsAug 3
Mkt Cap$1.35B
Vol1.3M
News
all
press releases
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF continues its investigation into Inspire Medical Systems, Inc. (NYSE: INSP). In August of 2025, contrary to the Companys repeated assurances that it had...
Business Wire
News Placeholder
More News
News Placeholder
INSP Highlights New OSA Data and PREDICTOR Study at SLEEP 2026
Inspire Medical's SLEEP 2026 updates spotlight new Inspire V data, remote patient tools and research supporting wider OSA therapy adoption.
Zacks
News Placeholder
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026...
Yahoo! Finance: News
News Placeholder
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?
NeuroPace exits DIXI, doubles down on RNS as Q1 narrows losses and lifts 2026 guidance, Medicare and pricing actions support margins.
Zacks
News Placeholder
Inspire Medical Systems (NYSE:INSP) Reaches New 12-Month Low on Analyst Downgrade
Inspire Medical Systems (NYSE:INSP) Sets New 1-Year Low After Analyst Downgrade...
MarketBeat
News Placeholder
JPMorgan Chase & Co. Cuts Inspire Medical Systems (NYSE:INSP) Price Target to $54.00
JPMorgan Chase & Co. lowered their target price on Inspire Medical Systems from $67.00 to $54.00 and set a "neutral" rating for the company in a research note on Tuesday...
MarketBeat
News Placeholder
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down
INSP beats Q1 estimates but slashes 2026 outlook as reimbursement disruptions and WISeR program weigh on growth and procedure volumes.
Zacks
News Placeholder
Stifel Nicolaus Lowers Inspire Medical Systems (NYSE:INSP) Price Target to $65.00
Stifel Nicolaus decreased their price objective on Inspire Medical Systems from $70.00 to $65.00 and set a "buy" rating on the stock in a report on Tuesday...
MarketBeat
News Placeholder
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $50.00 by Analysts at Truist Financial
Truist Financial cut their target price on Inspire Medical Systems from $64.00 to $50.00 and set a 'hold' rating for the company in a research note on Tuesday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.